CARDIOVASCULAR SAFETY IN THERAPY OF DIABETES MELLITUS TYPE 2

CARDIOVASCULAR SAFETY IN THERAPY OF DIABETES MELLITUS TYPE 2

Diabe tes mellitus is chronical disease, lead to vascular complications. The safety of hypoglycemic therapy influences on cardiovascular complications. In this review results of some large-scale clinic trials directed to prevention of cardiovascular complications are provided.

Bibliographic Details
Main Authors:	A. F. VERBOVOY, A. V. PASHENTSEVA, Y. A. DOLGIKH, A. S. OSINA, L. A. SHARONOVA
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	diabetes mellitus type 2 hypoglycemic therapy cardiovascular safety clinical trials
Online Access:	https://www.med-sovet.pro/jour/article/view/1638

Similar Items

Modern approaches to management of cardiovascular risk factors at patients with diabetes mellitus type 2
by: A F Verbovoy, et al.
Published: (2018-08-01)

Diabetes Drugs and Cardiovascular Safety
by: Ji Cheol Bae
Published: (2016-06-01)

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
by: Masayuki Ikeda, et al.
Published: (2019-07-01)

Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism
by: Kamesh Venkatakrishnan, et al.
Published: (2019-06-01)

Insulin resistance in therapeutic clinic
by: Anna V. Pashentseva, et al.
Published: (2017-09-01)

Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes
by: Rumiko Shimazawa, et al.
Published: (2019-12-01)

Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2010-12-01)

Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus
by: Gao F, et al.
Published: (2022-09-01)

New tendencies in the treatment of diabetic and cardiovascular diseases: a view of cardiologists
by: I. Z Bondarenko, et al.
Published: (2018-06-01)

Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019
by: Jiyun Park, et al.
Published: (2023-03-01)

Insulin biosimilars in clinical practice
by: A. F. Verbovoy, et al.
Published: (2022-01-01)

Hypoglycemic Drugs in Patients with Diabetes Mellitus and Heart Failure: A Narrative Review
by: Anastasia Nikolaidou, et al.
Published: (2024-05-01)

Nephrolithiasis against type 2 diabetes mellitus: on the effect of hypoglycemic therapy on lithogenesis
by: S K Yarovoy, et al.
Published: (2018-10-01)

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
by: Seung-Hyun Ko, et al.
Published: (2017-10-01)

Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
by: Ivan Ivanovich Dedov, et al.
Published: (2011-03-01)

Diabetes mellitus and cardiac arrhythmias
by: L. Yu. Morgunov
Published: (2024-04-01)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
by: Min Kyong Moon, et al.
Published: (2017-10-01)

Monotherapy in Patients with Type 2 Diabetes Mellitus
by: Sang Youl Rhee, et al.
Published: (2017-10-01)

Impact of hypoglycemic drugs on the course of COVID-19 in patients with type 2 diabetes mellitus
by: Yasmin Ahmed Ali El-Taravi, et al.
Published: (2023-04-01)

A review: Anti diabetic medicinal plants used for diabetes mellitus
by: G Arumugam, et al.
Published: (2013-01-01)

TYPE 2 DIABETES MELLITUS’S DECOMPENSATED FORM: ON THE PROBLEM OF EFFECTIVE PHARMACOTHERAPY IN REAL CLINICAL PRACTICE
by: A. V. Safronenko, et al.
Published: (2021-10-01)

The role of “latent autoimmune diabetes in adults” in the structure of diabetes mellitus in young people
by: A. K. Ovsyannikova, et al.
Published: (2022-01-01)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2013-06-01)

Quercetin Intake and Absolute Telomere Length in Patients with Type 2 Diabetes Mellitus: Novel Findings from a Randomized Controlled Before-and-After Study
by: Aikaterini E. Mantadaki, et al.
Published: (2024-08-01)

Association Between Fear of Hypoglycemia and Treatment Satisfaction Among Patients With Diabetes Mellitus
by: Hamideh Hakimi, et al.
Published: (2024-01-01)

Research progress of correlation between thyroid cancer and diabetes mellitus
by: FU Jing-lan, DENG Yuan-yuan, ZHANG Ying, ZHANG Xin-xu, CHEN Shi-jing, LIU Hui-xia
Published: (2022-04-01)

Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus
by: A S Ametov, et al.
Published: (2010-08-01)

Diabetes mellitus in the elderly: clinical and epidemiological characteristics of the all-Russian cohort of diabetic patients over 65 years
by: M. V. Shestakova, et al.
Published: (2025-01-01)

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
by: Cobble Michael E, et al.
Published: (2012-01-01)

Modern approaches to the treatment of type 2 diabetes mellitus
by: T. V. Morgunova, et al.
Published: (2018-03-01)

REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY"
by: A. A. Aleksandrov
Published: (2016-01-01)

Pharmacoepidemiological analysis of type 1 diabetes mellitus insulin therapy (According to the Moscow segment of the State Register of Diabetes Mellitus)
by: M. B. Antsiferov, et al.
Published: (2023-11-01)

Hypoglycemic effect of Galega Officinalis L. extracts at experimental diabetes mellitus
by: G. Ya. Kleveta, et al.
Published: (2009-09-01)

Effects of COVID-19 and diabetes mellitus on apolipoprotein A1 level in the blood plasma of patients
by: V.V. Pushkarev, et al.
Published: (2021-09-01)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Xiaoling Cai, et al.
Published: (2021-05-01)

Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients
by: Xiaoyu Chen, et al.
Published: (2024-08-01)

Quality of diabetes mellitus therapy in patients with chronic kidney disease in the real world
by: Beatrice Giampietro, et al.
Published: (2017-03-01)

Frequency of cardiovascular complications in patients with type 2 diabetes mellitus depending on antihyperglycemic therapy
by: Z.G. Krushinska, et al.
Published: (2018-09-01)

The specifics of cardiovascular disease and the role of self-monitoring in patients with type 2 diabetes
by: L. A. Sharonova, et al.
Published: (2015-12-01)

The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism
by: Xiaohui Pan, et al.
Published: (2020-12-01)